Skip to main content

Peer Review reports

From: The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial

Original Submission
10 Aug 2020 Submitted Original manuscript
10 Aug 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
12 Aug 2020 Editorially accepted
3 Sep 2020 Article published 10.1186/s13063-020-04680-w

You can find further information about peer review here.

Back to article page